Doximity upgraded to Strong Buy from Outperform at Raymond James

Raymond James upgraded Doximity (DOCS) to Strong Buy from Outperform with a price target of $65, down from $75. The stock’s risk/reward is “too compelling to ignore” following the post-earnings selloff, the analyst tells investors in a research note. The firm thinks Doximity’s long-term growth visibility is improving. Raymond James says the recent pullback has the shares at a discount to the vertical software group that is “too great to ignore.”